ImmunoCellular Therapeutics (IMUC)
OTHER OTC:IMUC
US Market
Holding IMUC?
Track your performance easily

ImmunoCellular Therapeutics (IMUC) Balance Sheet

180 Followers

ImmunoCellular Therapeutics Balance Sheet

ImmunoCellular Therapeutics's total assets for Q2 2018 were $3.83M, a decrease of -25.85% from the previous quarter. IMUC total liabilities were $401.94K for the fiscal quarter, a -73.08% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 17Dec 16Dec 15Dec 14Dec 13
Total Assets
$ 7.01M$ 16.89M$ 30.08M$ 25.18M$ 28.94M
Total Liabilities
$ 2.36M$ 10.76M$ 8.36M$ 1.89M$ 2.47M
Total Equity Gross Minority
$ 4.65M$ 6.13M$ 21.72M$ 23.29M$ 26.47M
Total Capitalization
$ 4.65M$ 6.13M$ 21.72M$ 23.29M$ 26.47M
Preferred Stock Equity
-----
Capital Lease Obligations
-----
Currency in USD

ImmunoCellular Therapeutics Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis